Andros Pharmaceuticals Co (ROCO:6917) Days Payable : 5.46 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Andros Pharmaceuticals Co Days Payable?

Andros Pharmaceuticals Co's average Accounts Payable for the six months ended in Dec. 2023 was NT$0.01 Mil. Andros Pharmaceuticals Co's Cost of Goods Sold for the six months ended in Dec. 2023 was NT$0.17 Mil. Hence, Andros Pharmaceuticals Co's Days Payable for the six months ended in Dec. 2023 was 5.46.

The historical rank and industry rank for Andros Pharmaceuticals Co's Days Payable or its related term are showing as below:

ROCO:6917' s Days Payable Range Over the Past 10 Years
Min: 3.71 Med: 3.71 Max: 3.71
Current: 3.71

During the past 5 years, Andros Pharmaceuticals Co's highest Days Payable was 3.71. The lowest was 3.71. And the median was 3.71.

ROCO:6917's Days Payable is ranked worse than
99.03% of 722 companies
in the Biotechnology industry
Industry Median: 148.53 vs ROCO:6917: 3.71

Andros Pharmaceuticals Co's Days Payable increased from Dec. 2022 (0.00) to Dec. 2023 (5.46). It may suggest that Andros Pharmaceuticals Co delayed paying its suppliers.

Andros Pharmaceuticals Co Days Payable Historical Data

The historical data trend for Andros Pharmaceuticals Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Andros Pharmaceuticals Co Days Payable Chart

Andros Pharmaceuticals Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

3.71

Andros Pharmaceuticals Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial			-	-	-	-	5.46

Competitive Comparison of Andros Pharmaceuticals Co's Days Payable

For the Biotechnology subindustry, Andros Pharmaceuticals Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Andros Pharmaceuticals Co's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Andros Pharmaceuticals Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Andros Pharmaceuticals Co's Days Payable falls into.

Andros Pharmaceuticals Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Andros Pharmaceuticals Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0.005)	/	1 )	/	0.492	*	365
=	0.005					/	0.492	*	365
=	3.71

Andros Pharmaceuticals Co's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0	+	0.005)	/	1 )	/	0.167	*	365 / 2
=	0.005					/	0.167	*	365 / 2
=	5.46

Andros Pharmaceuticals Co Days Payable Related Terms

Thank you for viewing the detailed overview of Andros Pharmaceuticals Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Andros Pharmaceuticals Co (ROCO:6917) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Andros Pharmaceuticals Co Ltd (ROCO:6917) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 22, Sec. 2, Shengyi Road, 6th Floor, Building D, Biotech Building, Hsinchu Biomedical Science Park, Hsinchu County, Zhubei City, TWN, 30261

Website

http://www.androspharma.com

Andros Pharmaceuticals Co Ltd is a biopharmaceutical company engaged in developing novel drug delivery platform technologies. The firm focuses on the development of topical new dosage forms and non-viral gene delivery systems, with the current pipeline indicated for pain management, DNA repair, and gene therapy. Its product line comprises New Dosage Forms (Topical), Super Generics (Topical), High-End Cosmetic Ingredients (Topical), and Gene Delivery Systems (Injectable).

Andros Pharmaceuticals Co (ROCO:6917) Headlines

No Headlines